Letter to Sanofi calling for patent withdrawals on critical TB drugs

TAG and OTMeds call on Sanofi to reverse its efforts to patent two obvious combinations of two critical drugs to prevent TB: rifapentine and isoniazid.

Read More →

Sanofi withdraws two patent applications on life-saving TB prevention drugs in Europe and in Indonesia

Activists urge Sanofi to do the same in other countries.

Read More →

Page 1 of 1 · Total posts: 2